Bin Xu
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 17
- Epigenetics and DNA Methylation 8
-
- MicroRNA in disease regulation 29
- Cancer-related molecular mechanisms research 27
- Co-authors
- Ming Chen (70 shared papers)Ninghan Feng (15 shared papers)Shuqiu Chen (31 shared papers)Na Tong (14 shared papers)Xiu−Yan Huang (6 shared papers)Han Guan (14 shared papers)Jun Tao (10 shared papers)Xinyu Huang (4 shared papers)
- Journals
- Frontiers in Oncology (13 papers)The Prostate (5 papers)Molecular Biology Reports (5 papers)Cancer Medicine (5 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bin Xu
235 papers receiving 5.7k citations
Bin Xu's Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 1.9k
- Molecular Biology 2.8k
- Oncology 580
- Health, Toxicology and Mutagenesis 297
- Geriatrics and Gerontology 60
Countries citing papers authored by Bin Xu
This map shows the geographic impact of Bin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Xu more than expected).
Fields of papers citing papers by Bin Xu
This network shows the impact of papers produced by Bin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Xu. The network helps show where Bin Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 240 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis Hit paper breakdown → | 2020 | 315 |
| 2 | 2013 | 185 | |
| 3 | 2010 | 172 | |
| 4 | 2009 | 170 | |
| 5 | 2010 | 149 | |
| 6 | 2011 | 146 | |
| 7 | 2013 | 130 | |
| 8 | 2018 | 128 | |
| 9 | 2016 | 120 | |
| 10 | 2009 | 115 | |
| 11 | 2010 | 97 | |
| 12 | 2020 | 84 | |
| 13 | Effect of cadmium and cigarette smoking on human semen quality. | 1995 | 83 |
| 14 | 2010 | 82 | |
| 15 | 2014 | 77 | |
| 16 | 2019 | 76 | |
| 17 | 2015 | 72 | |
| 18 | 2019 | 65 | |
| 19 | 2011 | 65 | |
| 20 | 2020 | 64 |
About Bin Xu
Bin Xu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 240 papers that have together received 5.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (27 papers), Circular RNAs in diseases (17 papers), Bladder and Urothelial Cancer Treatments (10 papers), Prostate Cancer Treatment and Research (9 papers), Epigenetics and DNA Methylation (8 papers), Cancer Research and Treatments (8 papers) and Cell Adhesion Molecules Research (7 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (2.8k citations), Oncology (580 citations), Health, Toxicology and Mutagenesis (297 citations) and Geriatrics and Gerontology (60 citations). Bin Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ming Chen, Ninghan Feng, Shuqiu Chen, Na Tong, Xiu−Yan Huang, Han Guan, Jun Tao, Xinyu Huang, Chunhui Liu and Jin Huang. Their work appears in journals such as Frontiers in Oncology, The Prostate, Molecular Biology Reports, Cancer Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.